In-office testing with the DCA® HbA1c test kit gives primary-care professionals the tools to fight the diabetes epidemic on the front lines. Early detection and tight glycemic control help mitigate the serious conditions that accompany diabetes: heart and kidney disease, limb neuropathy, retinopathy, and stroke. More importantly, patients identified as being at risk can stop or reverse disease progression through lifestyle adjustments and/or pharmacological treatment.
When paired with the DCA Vantage® Analyzer, the DCA HbA1c test kit provides fast, actionable test results to help you determine the effectiveness of a treatment plan, make therapeutic adjustments with greater confidence, and be certain that patients are complying with your recommendations.
DCA® HbA1c Reagent Kit* for DCA Vantage® AnalyzerDiagnose Diabetes and Identify At-risk Patients
Pomohli vám tieto informácie?
1 Lenters-Westra E, Slingerland RJ. Clin Chem. 2010;56(1):44.
*DCA HbA1c test kit 10698915 (an aid to diagnose diabetes and identify patients at risk for developing diabetes) is not available for sale in the U.S. Product availability varies by country.
†NGSP-certified/CLIA-waived.
The products/features shown on this web page are not commercially available in all countries. Due to regulatory reasons, their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
DCA, DCA Vantage, and all related marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. All other trademarks and brands are the property of their respective owners.